Ciftci, R. Et Al. 2014. Clinical significance of serum macrophage migration inhibitory factor (MIF) level in breast cancer.. 50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , (Illinois, United States Of America).

Ciftci, R., TAŞ, F., Aksit, E., VATANSEVER, S., KARABULUT, S., Sen, F., ... Yildiz, İ.(2014). Clinical significance of serum macrophage migration inhibitory factor (MIF) level in breast cancer. . 50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America

Ciftci, Rumeysa Et Al. "Clinical significance of serum macrophage migration inhibitory factor (MIF) level in breast cancer.," 50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 2014

Ciftci, Rumeysa Et Al. "Clinical significance of serum macrophage migration inhibitory factor (MIF) level in breast cancer.." 50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , Illinois, United States Of America, 2014

Ciftci, R. Et Al. (2014) . "Clinical significance of serum macrophage migration inhibitory factor (MIF) level in breast cancer.." 50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , Illinois, United States Of America.

@conferencepaper{conferencepaper, author={Rumeysa Ciftci Et Al. }, title={Clinical significance of serum macrophage migration inhibitory factor (MIF) level in breast cancer.}, congress name={50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)}, city={Illinois}, country={United States Of America}, year={2014}}